Change in Splenic Volume As a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation.

Gregor Duwe,Lukas Mueller,Christian Ruckes,Nikita Dhruva Fischer,Lisa Johanna Frey, Jan Hendrik Boerner, Niklas Roelz,Maximilian Haack,Peter Sparwasser,Tobias Jorg,Christopher C. M. Neumann,Igor Tsaur,Thomas Hoefner,Axel Haferkamp,Felix Hahn,Rene Mager,Maximilian Peter Brandt

Immuno-Oncology Technology（2023）

Cited 1|Views19

Key words

advanced urothelial carcinoma,advanced renal cell carcinoma,immunotherapy,immune checkpoint inhibitor,prognostic marker,predictive marker,splenic volume,artificial intelligence

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined